Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 7 Breast Neoplasms 5 Ovarian Neoplasms 4 Pancreatic Neoplasms 3 Colorectal Neoplasms, Hereditary Nonpolyposis 3 Triple Negative Breast Neoplasms 2 Neoplastic Syndromes, Hereditary 2 Hereditary Breast and Ovarian Cancer Syndrome 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Urogenital Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoproliferative Disorders 1 Kidney Neoplasms 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Fanconi Anemia, Complementation Group D1 1 Digestive System Neoplasms 1 Cytopenia 1 Congenital Bone Marrow Failure Syndromes 1 Colonic Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Intraductal, Noninfiltrating 1 Cancer Risk Syndrome 1

Interventions

Genetic Counseling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cancer Risk Syndrome × Genetic Counseling × Clear all

NCT04323774 2025-12-12

AYA-RISE

Dana-Farber Cancer Institute

Phase NA Active not recruiting

Cancer Risk Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡